In November last year, Marksans Pharma’s wholly-owned subsidiary received the USFDA’s final approval for for the over-the-counter Loperamide Hydrochloride Tablets USP, 2 mg.
In November last year, Marksans Pharma’s wholly-owned subsidiary received the USFDA’s final approval for for the over-the-counter Loperamide Hydrochloride Tablets USP, 2 mg.